BrainStorm Cell Therapeutics
treatment suggests effect in participants with less advanced disease | BrainStorm Cell Therapeutics
Company
Deck Type
Sector
Industry
Deck date
October 2022
Slide
3 of 15
Related slides by other companies
Theravance Biopharma
Investor Conference
November 2022
the effect of treatment on minute standing was most pronounced in patients with | Theravance Biopharma
NeuroSense Therapeutics
Investor Presentation
June 2023
als | NeuroSense Therapeutics
MindMed
Investor Day
June 2023
need for additional treatment options is clear individual variations diverse gad is not a once size fits all indication it is a very occurring conditions depression or may complicate treatment resistance fail first line treatment side effects effects which reduce compliance current choices come with the potential for long term side disorder | MindMed
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights